1-2030027-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000815.5(GABRD):c.1104C>T(p.Ala368=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.032 in 1,612,650 control chromosomes in the GnomAD database, including 1,063 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 106 hom., cov: 33)
Exomes 𝑓: 0.032 ( 957 hom. )
Consequence
GABRD
NM_000815.5 synonymous
NM_000815.5 synonymous
Scores
6
Clinical Significance
Conservation
PhyloP100: -3.34
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0015837848).
BP6
Variant 1-2030027-C-T is Benign according to our data. Variant chr1-2030027-C-T is described in ClinVar as [Benign]. Clinvar id is 460004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-2030027-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.34 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.1104C>T | p.Ala368= | synonymous_variant | 9/9 | ENST00000378585.7 | NP_000806.2 | |
GABRD | XM_017000936.2 | c.1809C>T | p.Ala603= | synonymous_variant | 8/8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.1143C>T | p.Ala381= | synonymous_variant | 9/9 | XP_011539496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRD | ENST00000378585.7 | c.1104C>T | p.Ala368= | synonymous_variant | 9/9 | 1 | NM_000815.5 | ENSP00000367848 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0288 AC: 4391AN: 152246Hom.: 106 Cov.: 33
GnomAD3 genomes
AF:
AC:
4391
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0396 AC: 9827AN: 248252Hom.: 290 AF XY: 0.0401 AC XY: 5409AN XY: 134996
GnomAD3 exomes
AF:
AC:
9827
AN:
248252
Hom.:
AF XY:
AC XY:
5409
AN XY:
134996
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0324 AC: 47277AN: 1460286Hom.: 957 Cov.: 32 AF XY: 0.0328 AC XY: 23798AN XY: 726424
GnomAD4 exome
AF:
AC:
47277
AN:
1460286
Hom.:
Cov.:
32
AF XY:
AC XY:
23798
AN XY:
726424
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0288 AC: 4390AN: 152364Hom.: 106 Cov.: 33 AF XY: 0.0312 AC XY: 2323AN XY: 74504
GnomAD4 genome
AF:
AC:
4390
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
2323
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
101
ALSPAC
AF:
AC:
105
ESP6500AA
AF:
AC:
27
ESP6500EA
AF:
AC:
237
ExAC
AF:
AC:
4660
Asia WGS
AF:
AC:
274
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Idiopathic generalized epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MutationTaster
Benign
P
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at